NUVB vs RCKT Stock Comparison
Compare NUVB and RCKT across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between NUVB and RCKT?
NUVB leads the current stock comparison as Nuvation Bio Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Nuvation Bio Inc. vs Rocket Pharmaceuticals, Inc.
NUVB leads
NUVB leads by 1 AIQ points, primarily on Quality, having only recently taken the lead back from RCKT.
Fragile: 2 of 5 evidence groups support NUVB, the lead recently changed hands, and its current signal state is conflicted.
Nuvation Bio Inc.
Rocket Pharmaceuticals, Inc.
The Algovestiq AIQ Score currently favors NUVB over RCKT, 39 versus 38 as of Sep 11, 2026. NUVB's advantage is driven primarily by stronger quality, while RCKT holds the stronger momentum profile. NUVB also shows the stronger technical structure relative to its 50-day moving average. 2 of 5 covered evidence groups favor NUVB today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. NUVB lead: Reversed — RCKT led by 2 AIQ points 30 sessions ago; NUVB now leads by 1.
Compare Nuvation Bio Inc. and Rocket Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare NUVB and RCKT against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality45 vs 29NUVB +16
- Momentum37 vs 42RCKT +5
- Risk Resilience43 vs 48RCKT +5
2 of 5 evidence groups favor NUVB. NUVB’s edge is concentrated in quality; RCKT keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
Largest factor move: Momentum -11
No new signals fired.
Largest factor move: Momentum -19
New signals
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
The lead changed hands: NUVB moved ahead of RCKT in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — NUVB and RCKT both carry a full feed there.
The central trade-off
NUVB (Nuvation Bio Inc.): the stronger current systematic profile, led by quality.
RCKT (Rocket Pharmaceuticals, Inc.): the counter-case, on momentum, risk resilience, fundamentals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
NUVBNUVB on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
RCKTRCKT on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
RCKTRCKT on the Momentum factor, by 5 points.
Lower downside
RCKTRCKT on Risk Resilience, by 5 points.
Analyst upside
NUVBNUVB on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | NUVB | RCKT | Note |
|---|---|---|---|
| Implied upside to target | +229.5% | +49.3% | NUVB has more room |
| Target dispersion | +10% | 0% | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 2 | 1 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
2 of 5 covered evidence groups favor NUVB. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 39 vs 38 |
| Fundamentals | RCKT | EPS growth -12.6% vs 3.6%; TTM ROE -49.7% vs -5.8% |
| Valuation | Not covered | Not covered |
| Technicals | NUVB | Price vs 50-day -5.1% vs -6.2%; vs 200-day 5.4% vs -3% |
| Risk Resilience | RCKT | Risk Resilience 43 vs 48 |
| Analyst expectations | NUVB | Target upside 229.5% vs 49.3% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of NUVB and RCKT and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
- Only 2 of 5 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on NUVB.
How the comparison changed
119 daily snapshots · May 4 – Sep 10NUVB lead: Reversed — RCKT led by 2 AIQ points 30 sessions ago; NUVB now leads by 1.
- Today
- NUVB +1
- 39 vs 38
- 7 sessions ago
- RCKT +2
- 47 vs 49
- 30 sessions ago
- RCKT +2
- 47 vs 49
- 90 sessions ago
- RCKT +4
- 47 vs 51
The lead changed hands 8 times in this window, most recently on Sep 10 when NUVB moved ahead of RCKT.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 1 bearish / 2 neutral, conflicted
- Golden Cross Active — bullish, trend, long horizon (7.37%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
1 bullish / 3 bearish / 1 neutral, conflicted
- Death Cross Active — bearish, trend, long horizon (0.47%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Downtrend Structure Active — bearish, trend, long horizon
NUVB leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved down over the latest session (price -3.34%, AIQ -3 points).
Price and the AIQ Score both moved down over the latest session (price -3.74%, AIQ -6 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1RCKT closes the Quality gap — currently 16 points behind, the largest single contributor to NUVB's edge.
- 2RCKT's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3NUVB's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
RCKT leads on balance| Metric | NUVB | RCKT |
|---|---|---|
| Revenue growth (YoY) | -61.9% | 0% |
| EPS growth (YoY) | -12.6% | 3.6% |
| Gross margin | 93.9% | 0% |
| Operating margin | -81% | 0% |
| Return on equity (TTM) | -49.7% | -5.8% |
| Debt to equity | 0.99 | 0.07 |
Performance
NUVB leads 4 of 6 windows| Metric | NUVB | RCKT |
|---|---|---|
| 1 week (5 sessions) | -9.4% | -9.8% |
| 1 month (20 sessions) | -2.2% | 2.1% |
| 3 months (63 sessions) | 37.1% | 33.8% |
| 6 months (126 sessions) | 36.8% | -27.8% |
| Year to date | -29.9% | -0.9% |
| 1 year (252 sessions) | 79.9% | 6.7% |
Technicals
NUVB has the stronger structure| Metric | NUVB | RCKT |
|---|---|---|
| RSI (14) | 37.2 | 50 |
| ADX (14) | 13.2 | 21.7 |
| Price vs 50-day | -5.1% | -6.2% |
| Price vs 200-day | 5.4% | -3% |
| Volatility (1M, annualized) | 59.1% | 64% |
Risk
RCKT is the more resilient| Metric | NUVB | RCKT |
|---|---|---|
| Beta | 1.75 | 1.93 |
| Sharpe ratio | 1.09 | 0.41 |
| Sortino ratio | 1.8 | 0.73 |
| Max drawdown | -57.5% | -50.9% |
| Current drawdown | -34.2% | -34.3% |
| Annualized volatility | 85.9% | 71.5% |
| Value at risk (95%) | -5.8% | -5.8% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, NUVB or RCKT?
On the Algovestiq AIQ Score, NUVB is the stronger of the two as of Sep 11, 2026, scoring 39 against RCKT's 38. The edge comes from quality. RCKT is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is NUVB or RCKT the better buy right now?
NUVB carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Fragile — 2 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.
Why does the AIQ Score favor NUVB over RCKT?
The composite weights Quality, Value, Momentum and Risk Resilience. NUVB leads Quality by 16 points; RCKT leads Momentum by 5 points; RCKT leads Risk Resilience by 5 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, NUVB or RCKT?
Analyst price targets imply +229.5% upside for NUVB and +49.3% for RCKT, so the Street currently favors NUVB. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, NUVB or RCKT?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, NUVB or RCKT?
RCKT on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, NUVB or RCKT?
RCKT on the Momentum factor, by 5 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, NUVB or RCKT?
RCKT is the more resilient of the two, so the other name carries the higher downside risk. RCKT on Risk Resilience, by 5 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is NUVB more profitable than RCKT?
RCKT leads on the comparable margin measures — gross margin 93.9% vs 0%; operating margin -81% vs 0%; ttm roe -49.7% vs -5.8%.
Is NUVB's lead over RCKT getting stronger or weaker?
NUVB lead: Reversed — RCKT led by 2 AIQ points 30 sessions ago; NUVB now leads by 1. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 8 times in that window, most recently on 2026-09-10, when NUVB moved ahead of RCKT.
What would change the NUVB vs RCKT verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: RCKT closes the Quality gap — currently 16 points behind, the largest single contributor to NUVB's edge; RCKT's Death Cross Active resolves — a bearish trend rule currently active against it; NUVB's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about NUVB and RCKT?
NUVB: 2 bullish / 1 bearish / 2 neutral, conflicted. RCKT: 1 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on NUVB is Golden Cross Active (bullish, long horizon). On RCKT it is Death Cross Active (bearish, long horizon).
Compare NUVB and RCKT with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.